Hepatitis C infection in HIV-1 natural viral suppressors

AIDS

Volumn 24, Issue 11, 2010, Pages 1689-1695

  Sajadi, Mohammad M ^a   Shakeri, Nahzinine ^a   Talwani, Rohit ^a   Redfield, Robert R ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

clearance; elite controller; hepatitis C; HIV; natural viral suppressor

Indexed keywords

ALANINE AMINOTRANSFERASE; ALPHA FETOPROTEIN; ASPARTATE AMINOTRANSFERASE; HEPATITIS B SURFACE ANTIGEN;

ADULT; ARTICLE; CD4 LYMPHOCYTE COUNT; CD8+ T LYMPHOCYTE; CLEARANCE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; FEMALE; GENOTYPE; HEPATITIS C; HEREDITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN TISSUE; INFECTION; INFECTION RISK; LIVER CIRRHOSIS; LIVER HISTOLOGY; MAJOR CLINICAL STUDY; MALE; MIXED INFECTION; NATURAL VIRAL SUPPRESSOR; PRIORITY JOURNAL; VIRUS INHIBITION; VIRUS LOAD;

CD4 LYMPHOCYTE COUNT; COHORT STUDIES; CROSS-SECTIONAL STUDIES; FEMALE; HEPACIVIRUS; HEPATITIS C; HEPATITIS C, CHRONIC; HIV INFECTIONS; HIV LONG-TERM SURVIVORS; HIV-1; HUMANS; MALE; MIDDLE AGED; VIRAL LOAD; VIRUS REPLICATION;

EID: 77954348400     PISSN: 02699370     EISSN: 14735571     Source Type: Journal    
DOI: 10.1097/QAD.0b013e32833a2a32     Document Type: Article

References (30)

1. Sajadi MM, Heredia A, LeN, Constantine N, Redfield RR. HIV-1 natural viral suppressors: control of viral replication in the absence of therapy. AIDS 2007; 21:517-519.
2. Sajadi MM, Constantine NT, Mann DL, Charurat M, Dadzan E, Kadlecik P, Redfield RR. Epidemiologic characteristics and natural history of HIV-1 natural viral suppressors. J Acquir Immune Defic Syndr 2009; 50:403-408; PMID: 19214118.
3. Pereyra F, Addo MM, Kaufmann DE, Liu Y, Miura T, Rathod A, et al. Genetic and immunologic heterogeneity among persons who control HIV infection in the absence of therapy. J Infect Dis 2008; 197:563-571.
4. Bailey JR, Lassen KG, Yang HC, Quinn TC, Ray SC, Blankson JN, Siliciano RF. Neutralizing antibodies do not mediate suppression of human immunodeficiency virus type 1 in elite suppressors or selection of plasma virus variants in patients on highly active antiretroviral therapy. J Virol 2006; 80:4758-4770.
5. LambotteO, BoufassaF, MadecY, NguyenA, Goujard C, Meyer L, et al. HIV controllers: a homogeneous group of HIV-1-infected patients with spontaneous control of viral replication. Clin Infect Dis 2005; 41:1053-1056.
6. Castro P, Laguno M, Nomdedeu M, López A, Plana M, Fumero E, et al. Clinicoimmunological progression and response to treatment of long-term nonprogressor HIV-hepatitis C virus-co-infected patients. AIDS Res Hum Retroviruses 2007; 23:863-867.
7. Morisca G, Bagaglio S, Ghezzi S, Lodrini C, Vicenzi E, Santa-gostino E, et al. Hepatitis C virus (HCV) co-infection in a cohort of HIV positive long-term nonprogressors: possible protective effect of infecting HCV genotype on HIV disease progression. J Clin Virol 2007; 39:82-86.
8. Grebely J, Raffa JD, Lai C, Krajden M, Conway B, Tyndall MW. Factors associated with spontaneous clearance of hepatitis C virus among illicit drug users. Can J Gastroenterol 2007; 21:447-451.
9. Page K, Hahn JA, Evans J, Shiboski S, Lum P, Delwart E, et al. Acute hepatitis C virus infection in young adult injection drug users: a prospective study of incident infection, resolution, and reinfection. J Infect Dis 2009; 200:1216-1226.
10. Wang CC, Krantz E, Klarquist J, Krows M, McBride L, Scott EP, et al. Acute hepatitis C in a contemporary US cohort: modes of acquisition and factors influencing viral clearance. J Infect Dis 2007; 196:1474-1482.
11. Bakr I, Rekacewicz C, El Hosseiny M, Ismail S, El Daly M, El-Kafrawy S, et al. Higher clearance of hepatitis C virus infection in females compared with males. Gut 2006; 55: 1183-1187.
12. Micallef JM, Kaldor JM, Dore GJ. Spontaneous viral clearance following acute hepatitis C infection: a systematic review of longitudinal studies. J Viral Hepat 2006; 13:34-41.
13. Thomas DL, Astemborski J, Rai RM, Anania FA, Schaeffer M, Galai N, et al. The natural history of hepatitis C virus infection: host, viral, and environmental factors. JAMA 2000; 284:450-456.
14. Soriano V, Sulkowski M, Bergin C, Hatzakis A, Cacoub P, Katlama C, et al. Care of patients with chronic hepatitis C and HIV co-infection: recommendations from the HIV-HCV International Panel. AIDS 2002; 16:813-828.
15. Thomas DL, Thio CL, Martin MP, Qi Y, Ge D, O?Huigin C, et al. Genetic variation in IL28B and spontaneous clearance of hepatitis C virus. Nature 2009; 461:798-801.
16. Greub G, Lederberger B, Battegay M, Grob P, Perrin L, Furrer H, et al. Clinical progression, survival, and immune recovery during antiretroviral therapy in patients with HIV-1 and hepatitis C virus co-infection: the Swiss HIV Cohort study. Lancet 2000; 356:1800-1805.
17. Benhamou Y, Bochet M, Di Martino V, Charlotte F, Azria F, Coutellier A, et al. Liver fibrosis progression in human immunodeficiency virus and hepatitis C virus co-infected patients. The Multivirc Group. Hepatology 1999; 30:1054-1058. (Pubitemid 29458296)
18. Graham CS, Baden LR, Yu E, Mrus JM, Carnie J, Heeren T, Koziel MJ. Influence of human immunodeficiency virus infection on the course of hepatitis C virus infection: a meta-analysis. Clin Infect Dis 2001; 33:562-569.
19. Di Martino V, Rufat P, Boyer N, Renard P, Degos F, Martinot-Peignoux M, et al. The influence of human immunodeficiency virus co-infection on chronic hepatitis C in injection drug users: a long-term retrospective cohort study. Hepatology 2001; 34:1193-1199.
20. Thomas DL, Shih JW, Alter HJ, Vlahov D, Cohn S, Hoover DR, et al. Effect of human immunodeficiency virus on hepatitis C virus infection among injecting drug users. JID 1996; 174:690-695. (Pubitemid 26325882)
21. Beld M, PenningM, LukashovV, McMorrow M, Roos M, Pakker N, et al. Evidence that both HIV and HIV-induced immunodeficiency enhance HCV replication among HCV seroconverters. Virology 1998; 244:504-512.
22. Soriano V, Bravo R, Mas A, Garcia-Samaniego J, Guierrez M, Gonzalez-Lahoz J. Impact of immunosuppression caused by HIV infection on the replication of hepatitis C virus. Vox Sang 1995; 69:259-260.
23. Cribier B, Rey D, Schmitt C, Lang JM, Kirn A, Stoll-Keller F. High hepatitis C viraemia and impaired antibody response in patients co-infected with HIV. AIDS 1995; 9:1131-1136.
24. Capa L, Soriano V, Garćia-Samaniego J, Nuñez M, Romero M, Cascajero A, et al. Influence of HCV genotype and co-infection with HIV on CD4(R) and CD8(R) T-cell responses to hepatitis C virus. J Med Virol 2007; 79:503-510.
25. Pereyra F, Palmer S, Miura T, Block BL, Wiegand A, Rothchild AC, et al. Persistent low-level viremia in HIV-1 elite controller and relationship to immunological parameters. J Infect Dis 2009; 200:984-990.
26. d?Arminio Monforte A, Cozzi-Lepri A, Castagna A, Antinori A, De Luca A, Mussini C, et al. Risk of developing specific AIDS-defining illnesses in patients co-infected with HIV and hepatitis C virus with or without liver cirrhosis. Clin Infect Dis 2009; 49:612-622.
27. De Luca A, Bugarini R, Lepri AC, Puoti M, Girardi E, Antinori A, et al. Co-infection with hepatitis viruses and outcome of initial antiretroviral regimens in previously naive HIV-infected subjects. Arch Intern Med 2002; 162:2125-2132.
28. Sulkowski MS, Mooro RD, Mehta SH, Chaisson RE, Thomas DL. Hepatitis C and progression of HIV disease. JAMA 2002; 288:199-206.
29. McGovern BH, GolanY, LopezM, Pratt D, Lawton A, Moore G, et al. The impact of cirrhosis on CD4R T cell counts in HIV-seronegative patients. Clin Infect Dis 2007; 44:431-437.
30. Núñez M, Soriano V, López M, Ballesteros C, Cascajero A, González-Lahoz J, Benito JM. Co-infection with hepatitis C virus increases lymphocyte apoptosis in HIV-infected patients. Clin Infect Dis 2006; 43:1209-1212.